Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

March 23, 2015

Primary Completion Date

October 16, 2017

Study Completion Date

February 28, 2018

Conditions
Ischemic Stroke
Interventions
DRUG

Tenecteplase

DRUG

Tissue Plasminogen Activator

Trial Locations (18)

1001

Auckland Hospital, Grafton

2050

Royal Prince Alfred Hospital, Camperdown

2065

Royal North Shore Hospital, St Leonards

2145

Westmead Hospital, Westmead

2250

Gosford Hospital, Gosford

3004

Alfred Hospital, Melbourne

3021

Western Heath, St Albans

3050

Royal Melbourne Hospital, Melbourne

3128

Box Hill Hospital, Box Hill

3168

Monash Medical Centre, Clayton

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

5112

Lyell McEwin Hospital, Elizabeth Vale

8011

Christchurch Hospital, Christchurch

Unknown

John Hunter Hospital, Newcastle

Royal Brisbane & Women's Hospital, Brisbane

Gold Coast University Hospital, Gold Coast

Austin Hospital, Heidelberg

Sponsors
All Listed Sponsors
collaborator

The Florey Institute of Neuroscience and Mental Health

OTHER

lead

Neuroscience Trials Australia

OTHER

NCT02388061 - Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke | Biotech Hunter | Biotech Hunter